Indications and uses
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
relieves occasional constipation (irregularity) generally produces bowel movement in 12 to 72 hours
adults and children 12 years and older: take 1-2 tablets daily until first bowel movement; 1 tablet daily thereafter, or as directed by doctor children under 12: consult a doctor do not exceed recommended dose
each tablet contains: calcium 50 mg, sodium 8 mg for institutional use only package not child resistant store at room temperature 15°C-30°C (59°F-86°F) Tamper Evident: Do not use if imprinted seal under cap is missing or broken
Docusate Sodium 100 mg
Stool Softener Laxative
Ask a doctor before use if you
Stop use and ask a doctor if
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
cellulose, croscarmellose sodium, dicalcium phosphate, magnesium stearate, silica, stearic acid, talc
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 49348-167-10 | EA - Each | 49348-167 | 169459e0-e681-4701-9858-8791fde95cce | 1 | 2020-06-05 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 49348-167 | 49348-167-10 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| STEARIC ACID | 4ELV7Z65AP | IACT |
| DOCUSATE SODIUM | F05Q2T2JA0 | ACTIB |
| CROSCARMELLOSE SODIUM | M28OL1HH48 | IACT |
| MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IACT |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | L11K75P92J | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
| SILICON DIOXIDE | ETJ7Z6XBU4 | IACT |
| TALC | 7SEV7J4R1U | IACT |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2f736207-21cc-19b4-e063-6394a90a30f0 | 3ec5faa4-ff42-0862-e054-00144ff8d46c | 2025-03-03 | Warnings | 2f736207-21cc-19b4-e063-6394a90a30f0 3ec5faa4-ff42-0862-e054-00144ff8d46c |
Adverse event summaries are temporarily unavailable. Other product information remains available.